The global Pet Biopharmaceuticals Market was valued at US$ 4,200 million in 2024 and is projected to reach US$ 7,100 million by 2030, at a CAGR of 9.1% during the forecast period.
Report Overview
This report provides a deep insight into the global Pet Biopharmaceuticals market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pet Biopharmaceuticals Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pet Biopharmaceuticals market in any manner.
Global Pet Biopharmaceuticals Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Zoetis
- Boehringer Ingelheim
- Merck
- Elanco
- Virbac
- Dechra Veterinary Products
- Ceva
- Vetoquinol
- Ouro Fino Saude
- Norbrook
- Jindun
- Chopperlvya Animal Health
- CAHIC
- Including or Excluding key companies relevant to your analysis.
Market Segmentation (by Type)
- Antiparasitic
- Biological Products
- Antibacterial
- Others
Market Segmentation (by Application)
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Pet Biopharmaceuticals Market
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pet Biopharmaceuticals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Pet Biopharmaceuticals
1.2 Key Market Segments
1.2.1 Pet Biopharmaceuticals Segment by Type
1.2.2 Pet Biopharmaceuticals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Pet Biopharmaceuticals Market Overview
2.1 Global Market Overview
2.1.1 Global Pet Biopharmaceuticals Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Pet Biopharmaceuticals Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Pet Biopharmaceuticals Market Competitive Landscape
3.1 Global Pet Biopharmaceuticals Sales by Manufacturers (2019-2024)
3.2 Global Pet Biopharmaceuticals Revenue Market Share by Manufacturers (2019-2024)
3.3 Pet Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pet Biopharmaceuticals Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Pet Biopharmaceuticals Sales Sites, Area Served, Product Type
3.6 Pet Biopharmaceuticals Market Competitive Situation and Trends
3.6.1 Pet Biopharmaceuticals Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pet Biopharmaceuticals Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Pet Biopharmaceuticals Industry Chain Analysis
4.1 Pet Biopharmaceuticals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Pet Biopharmaceuticals Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Pet Biopharmaceuticals Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pet Biopharmaceuticals Sales Market Share by Type (2019-2024)
6.3 Global Pet Biopharmaceuticals Market Size Market Share by Type (2019-2024)
6.4 Global Pet Biopharmaceuticals Price by Type (2019-2024)
7 Pet Biopharmaceuticals Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pet Biopharmaceuticals Market Sales by Application (2019-2024)
7.3 Global Pet Biopharmaceuticals Market Size (M USD) by Application (2019-2024)
7.4 Global Pet Biopharmaceuticals Sales Growth Rate by Application (2019-2024)
8 Pet Biopharmaceuticals Market Segmentation by Region
8.1 Global Pet Biopharmaceuticals Sales by Region
8.1.1 Global Pet Biopharmaceuticals Sales by Region
8.1.2 Global Pet Biopharmaceuticals Sales Market Share by Region
8.2 North America
8.2.1 North America Pet Biopharmaceuticals Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pet Biopharmaceuticals Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pet Biopharmaceuticals Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pet Biopharmaceuticals Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pet Biopharmaceuticals Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Zoetis
9.1.1 Zoetis Pet Biopharmaceuticals Basic Information
9.1.2 Zoetis Pet Biopharmaceuticals Product Overview
9.1.3 Zoetis Pet Biopharmaceuticals Product Market Performance
9.1.4 Zoetis Business Overview
9.1.5 Zoetis Pet Biopharmaceuticals SWOT Analysis
9.1.6 Zoetis Recent Developments
9.2 Boehringer Ingelheim
9.2.1 Boehringer Ingelheim Pet Biopharmaceuticals Basic Information
9.2.2 Boehringer Ingelheim Pet Biopharmaceuticals Product Overview
9.2.3 Boehringer Ingelheim Pet Biopharmaceuticals Product Market Performance
9.2.4 Boehringer Ingelheim Business Overview
9.2.5 Boehringer Ingelheim Pet Biopharmaceuticals SWOT Analysis
9.2.6 Boehringer Ingelheim Recent Developments
9.3 Merck
9.3.1 Merck Pet Biopharmaceuticals Basic Information
9.3.2 Merck Pet Biopharmaceuticals Product Overview
9.3.3 Merck Pet Biopharmaceuticals Product Market Performance
9.3.4 Merck Pet Biopharmaceuticals SWOT Analysis
9.3.5 Merck Business Overview
9.3.6 Merck Recent Developments
9.4 Elanco
9.4.1 Elanco Pet Biopharmaceuticals Basic Information
9.4.2 Elanco Pet Biopharmaceuticals Product Overview
9.4.3 Elanco Pet Biopharmaceuticals Product Market Performance
9.4.4 Elanco Business Overview
9.4.5 Elanco Recent Developments
9.5 Virbac
9.5.1 Virbac Pet Biopharmaceuticals Basic Information
9.5.2 Virbac Pet Biopharmaceuticals Product Overview
9.5.3 Virbac Pet Biopharmaceuticals Product Market Performance
9.5.4 Virbac Business Overview
9.5.5 Virbac Recent Developments
9.6 Dechra Veterinary Products
9.6.1 Dechra Veterinary Products Pet Biopharmaceuticals Basic Information
9.6.2 Dechra Veterinary Products Pet Biopharmaceuticals Product Overview
9.6.3 Dechra Veterinary Products Pet Biopharmaceuticals Product Market Performance
9.6.4 Dechra Veterinary Products Business Overview
9.6.5 Dechra Veterinary Products Recent Developments
9.7 Ceva
9.7.1 Ceva Pet Biopharmaceuticals Basic Information
9.7.2 Ceva Pet Biopharmaceuticals Product Overview
9.7.3 Ceva Pet Biopharmaceuticals Product Market Performance
9.7.4 Ceva Business Overview
9.7.5 Ceva Recent Developments
9.8 Vetoquinol
9.8.1 Vetoquinol Pet Biopharmaceuticals Basic Information
9.8.2 Vetoquinol Pet Biopharmaceuticals Product Overview
9.8.3 Vetoquinol Pet Biopharmaceuticals Product Market Performance
9.8.4 Vetoquinol Business Overview
9.8.5 Vetoquinol Recent Developments
9.9 Ouro Fino Saude
9.9.1 Ouro Fino Saude Pet Biopharmaceuticals Basic Information
9.9.2 Ouro Fino Saude Pet Biopharmaceuticals Product Overview
9.9.3 Ouro Fino Saude Pet Biopharmaceuticals Product Market Performance
9.9.4 Ouro Fino Saude Business Overview
9.9.5 Ouro Fino Saude Recent Developments
9.10 Norbrook
9.10.1 Norbrook Pet Biopharmaceuticals Basic Information
9.10.2 Norbrook Pet Biopharmaceuticals Product Overview
9.10.3 Norbrook Pet Biopharmaceuticals Product Market Performance
9.10.4 Norbrook Business Overview
9.10.5 Norbrook Recent Developments
9.11 Jindun
9.11.1 Jindun Pet Biopharmaceuticals Basic Information
9.11.2 Jindun Pet Biopharmaceuticals Product Overview
9.11.3 Jindun Pet Biopharmaceuticals Product Market Performance
9.11.4 Jindun Business Overview
9.11.5 Jindun Recent Developments
9.12 Chopperlvya Animal Health
9.12.1 Chopperlvya Animal Health Pet Biopharmaceuticals Basic Information
9.12.2 Chopperlvya Animal Health Pet Biopharmaceuticals Product Overview
9.12.3 Chopperlvya Animal Health Pet Biopharmaceuticals Product Market Performance
9.12.4 Chopperlvya Animal Health Business Overview
9.12.5 Chopperlvya Animal Health Recent Developments
9.13 CAHIC
9.13.1 CAHIC Pet Biopharmaceuticals Basic Information
9.13.2 CAHIC Pet Biopharmaceuticals Product Overview
9.13.3 CAHIC Pet Biopharmaceuticals Product Market Performance
9.13.4 CAHIC Business Overview
9.13.5 CAHIC Recent Developments
10 Pet Biopharmaceuticals Market Forecast by Region
10.1 Global Pet Biopharmaceuticals Market Size Forecast
10.2 Global Pet Biopharmaceuticals Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pet Biopharmaceuticals Market Size Forecast by Country
10.2.3 Asia Pacific Pet Biopharmaceuticals Market Size Forecast by Region
10.2.4 South America Pet Biopharmaceuticals Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pet Biopharmaceuticals by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Pet Biopharmaceuticals Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Pet Biopharmaceuticals by Type (2025-2030)
11.1.2 Global Pet Biopharmaceuticals Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Pet Biopharmaceuticals by Type (2025-2030)
11.2 Global Pet Biopharmaceuticals Market Forecast by Application (2025-2030)
11.2.1 Global Pet Biopharmaceuticals Sales (Kilotons) Forecast by Application
11.2.2 Global Pet Biopharmaceuticals Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pet Biopharmaceuticals Market Size Comparison by Region (M USD)
Table 5. Global Pet Biopharmaceuticals Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Pet Biopharmaceuticals Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Pet Biopharmaceuticals Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Pet Biopharmaceuticals Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Biopharmaceuticals as of 2022)
Table 10. Global Market Pet Biopharmaceuticals Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Pet Biopharmaceuticals Sales Sites and Area Served
Table 12. Manufacturers Pet Biopharmaceuticals Product Type
Table 13. Global Pet Biopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pet Biopharmaceuticals
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pet Biopharmaceuticals Market Challenges
Table 22. Global Pet Biopharmaceuticals Sales by Type (Kilotons)
Table 23. Global Pet Biopharmaceuticals Market Size by Type (M USD)
Table 24. Global Pet Biopharmaceuticals Sales (Kilotons) by Type (2019-2024)
Table 25. Global Pet Biopharmaceuticals Sales Market Share by Type (2019-2024)
Table 26. Global Pet Biopharmaceuticals Market Size (M USD) by Type (2019-2024)
Table 27. Global Pet Biopharmaceuticals Market Size Share by Type (2019-2024)
Table 28. Global Pet Biopharmaceuticals Price (USD/Ton) by Type (2019-2024)
Table 29. Global Pet Biopharmaceuticals Sales (Kilotons) by Application
Table 30. Global Pet Biopharmaceuticals Market Size by Application
Table 31. Global Pet Biopharmaceuticals Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Pet Biopharmaceuticals Sales Market Share by Application (2019-2024)
Table 33. Global Pet Biopharmaceuticals Sales by Application (2019-2024) & (M USD)
Table 34. Global Pet Biopharmaceuticals Market Share by Application (2019-2024)
Table 35. Global Pet Biopharmaceuticals Sales Growth Rate by Application (2019-2024)
Table 36. Global Pet Biopharmaceuticals Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Pet Biopharmaceuticals Sales Market Share by Region (2019-2024)
Table 38. North America Pet Biopharmaceuticals Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Pet Biopharmaceuticals Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Pet Biopharmaceuticals Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Pet Biopharmaceuticals Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Pet Biopharmaceuticals Sales by Region (2019-2024) & (Kilotons)
Table 43. Zoetis Pet Biopharmaceuticals Basic Information
Table 44. Zoetis Pet Biopharmaceuticals Product Overview
Table 45. Zoetis Pet Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Zoetis Business Overview
Table 47. Zoetis Pet Biopharmaceuticals SWOT Analysis
Table 48. Zoetis Recent Developments
Table 49. Boehringer Ingelheim Pet Biopharmaceuticals Basic Information
Table 50. Boehringer Ingelheim Pet Biopharmaceuticals Product Overview
Table 51. Boehringer Ingelheim Pet Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Boehringer Ingelheim Business Overview
Table 53. Boehringer Ingelheim Pet Biopharmaceuticals SWOT Analysis
Table 54. Boehringer Ingelheim Recent Developments
Table 55. Merck Pet Biopharmaceuticals Basic Information
Table 56. Merck Pet Biopharmaceuticals Product Overview
Table 57. Merck Pet Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Merck Pet Biopharmaceuticals SWOT Analysis
Table 59. Merck Business Overview
Table 60. Merck Recent Developments
Table 61. Elanco Pet Biopharmaceuticals Basic Information
Table 62. Elanco Pet Biopharmaceuticals Product Overview
Table 63. Elanco Pet Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Elanco Business Overview
Table 65. Elanco Recent Developments
Table 66. Virbac Pet Biopharmaceuticals Basic Information
Table 67. Virbac Pet Biopharmaceuticals Product Overview
Table 68. Virbac Pet Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Virbac Business Overview
Table 70. Virbac Recent Developments
Table 71. Dechra Veterinary Products Pet Biopharmaceuticals Basic Information
Table 72. Dechra Veterinary Products Pet Biopharmaceuticals Product Overview
Table 73. Dechra Veterinary Products Pet Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Dechra Veterinary Products Business Overview
Table 75. Dechra Veterinary Products Recent Developments
Table 76. Ceva Pet Biopharmaceuticals Basic Information
Table 77. Ceva Pet Biopharmaceuticals Product Overview
Table 78. Ceva Pet Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Ceva Business Overview
Table 80. Ceva Recent Developments
Table 81. Vetoquinol Pet Biopharmaceuticals Basic Information
Table 82. Vetoquinol Pet Biopharmaceuticals Product Overview
Table 83. Vetoquinol Pet Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Vetoquinol Business Overview
Table 85. Vetoquinol Recent Developments
Table 86. Ouro Fino Saude Pet Biopharmaceuticals Basic Information
Table 87. Ouro Fino Saude Pet Biopharmaceuticals Product Overview
Table 88. Ouro Fino Saude Pet Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Ouro Fino Saude Business Overview
Table 90. Ouro Fino Saude Recent Developments
Table 91. Norbrook Pet Biopharmaceuticals Basic Information
Table 92. Norbrook Pet Biopharmaceuticals Product Overview
Table 93. Norbrook Pet Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Norbrook Business Overview
Table 95. Norbrook Recent Developments
Table 96. Jindun Pet Biopharmaceuticals Basic Information
Table 97. Jindun Pet Biopharmaceuticals Product Overview
Table 98. Jindun Pet Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Jindun Business Overview
Table 100. Jindun Recent Developments
Table 101. Chopperlvya Animal Health Pet Biopharmaceuticals Basic Information
Table 102. Chopperlvya Animal Health Pet Biopharmaceuticals Product Overview
Table 103. Chopperlvya Animal Health Pet Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Chopperlvya Animal Health Business Overview
Table 105. Chopperlvya Animal Health Recent Developments
Table 106. CAHIC Pet Biopharmaceuticals Basic Information
Table 107. CAHIC Pet Biopharmaceuticals Product Overview
Table 108. CAHIC Pet Biopharmaceuticals Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. CAHIC Business Overview
Table 110. CAHIC Recent Developments
Table 111. Global Pet Biopharmaceuticals Sales Forecast by Region (2025-2030) & (Kilotons)
Table 112. Global Pet Biopharmaceuticals Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Pet Biopharmaceuticals Sales Forecast by Country (2025-2030) & (Kilotons)
Table 114. North America Pet Biopharmaceuticals Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Pet Biopharmaceuticals Sales Forecast by Country (2025-2030) & (Kilotons)
Table 116. Europe Pet Biopharmaceuticals Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Pet Biopharmaceuticals Sales Forecast by Region (2025-2030) & (Kilotons)
Table 118. Asia Pacific Pet Biopharmaceuticals Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Pet Biopharmaceuticals Sales Forecast by Country (2025-2030) & (Kilotons)
Table 120. South America Pet Biopharmaceuticals Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Pet Biopharmaceuticals Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Pet Biopharmaceuticals Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Pet Biopharmaceuticals Sales Forecast by Type (2025-2030) & (Kilotons)
Table 124. Global Pet Biopharmaceuticals Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Pet Biopharmaceuticals Price Forecast by Type (2025-2030) & (USD/Ton)
Table 126. Global Pet Biopharmaceuticals Sales (Kilotons) Forecast by Application (2025-2030)
Table 127. Global Pet Biopharmaceuticals Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Pet Biopharmaceuticals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pet Biopharmaceuticals Market Size (M USD), 2019-2030
Figure 5. Global Pet Biopharmaceuticals Market Size (M USD) (2019-2030)
Figure 6. Global Pet Biopharmaceuticals Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pet Biopharmaceuticals Market Size by Country (M USD)
Figure 11. Pet Biopharmaceuticals Sales Share by Manufacturers in 2023
Figure 12. Global Pet Biopharmaceuticals Revenue Share by Manufacturers in 2023
Figure 13. Pet Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Pet Biopharmaceuticals Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pet Biopharmaceuticals Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pet Biopharmaceuticals Market Share by Type
Figure 18. Sales Market Share of Pet Biopharmaceuticals by Type (2019-2024)
Figure 19. Sales Market Share of Pet Biopharmaceuticals by Type in 2023
Figure 20. Market Size Share of Pet Biopharmaceuticals by Type (2019-2024)
Figure 21. Market Size Market Share of Pet Biopharmaceuticals by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pet Biopharmaceuticals Market Share by Application
Figure 24. Global Pet Biopharmaceuticals Sales Market Share by Application (2019-2024)
Figure 25. Global Pet Biopharmaceuticals Sales Market Share by Application in 2023
Figure 26. Global Pet Biopharmaceuticals Market Share by Application (2019-2024)
Figure 27. Global Pet Biopharmaceuticals Market Share by Application in 2023
Figure 28. Global Pet Biopharmaceuticals Sales Growth Rate by Application (2019-2024)
Figure 29. Global Pet Biopharmaceuticals Sales Market Share by Region (2019-2024)
Figure 30. North America Pet Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Pet Biopharmaceuticals Sales Market Share by Country in 2023
Figure 32. U.S. Pet Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Pet Biopharmaceuticals Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Pet Biopharmaceuticals Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Pet Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Pet Biopharmaceuticals Sales Market Share by Country in 2023
Figure 37. Germany Pet Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Pet Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Pet Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Pet Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Pet Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Pet Biopharmaceuticals Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Pet Biopharmaceuticals Sales Market Share by Region in 2023
Figure 44. China Pet Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Pet Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Pet Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Pet Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Pet Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Pet Biopharmaceuticals Sales and Growth Rate (Kilotons)
Figure 50. South America Pet Biopharmaceuticals Sales Market Share by Country in 2023
Figure 51. Brazil Pet Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Pet Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Pet Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Pet Biopharmaceuticals Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Pet Biopharmaceuticals Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Pet Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Pet Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Pet Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Pet Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Pet Biopharmaceuticals Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Pet Biopharmaceuticals Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Pet Biopharmaceuticals Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Pet Biopharmaceuticals Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Pet Biopharmaceuticals Market Share Forecast by Type (2025-2030)
Figure 65. Global Pet Biopharmaceuticals Sales Forecast by Application (2025-2030)
Figure 66. Global Pet Biopharmaceuticals Market Share Forecast by Application (2025-2030)
